"By selling Tirzepatide ODT, Empower is essentially conducting a mass testing experiment on consumers." In a statement to Houston Public Media, a spokesperson for Empower Pharmacy said the company does not produce copies of Eli Lillys drugs and does not violate any federal or state laws
Compounded drugs can be important for overcoming shortages or meeting unique patient needsbut compounders should not try to compound drugs in a way that circumvents FDAs approval process." The FDA claims the companies are mass marketing their GLP-1s as similar alternatives to FDA-approved drugs
The tirzepatide participants who received the drug once a week shed 15-20 percent of their body weight on average over 72 weeks, compared to the placebo group
Sanjoy Dutta, chief scientific officer at Breakthrough T1D (formerly JDRF)
Blanco explains: Part of the medical approach is to minimize and individualize doses for each patient in order to achieve the lowest possible incidence of side effects. The key lies in personalization and gradual treatment adjustment
But its not the medicine itself that causes muscle mass loss